Wireless News
02-01-2006
LDR Spine Gets FDA Approval to Conduct Clinical Trial for a Second- Generation Cervical Artificial Disc
WIRELESS NEWS-February 1, 2006-LDR Spine Gets FDA Approval to Conduct…
THE PAINKILLER Mobic saw sharp gains in new users in the days following Pfizer’s withdrawal of COX-2 drug Bextra.
In the week ending April 8, nearly 25 percent of former Bextra patients switched to Mobic, which is jointly marketed by Abbott Laboratories and Boehringer Ingelheim, according to data from Verispan’s Vector One.
Bear Stearns analyst Rick Wise said in published repo…
Related Results
MobicMobicMobic approvalMobic escapes boxed warning.MOBIC - Brief Article
> The Food and Drug Administration has approved the use of Mobic as a treatment for rheumatoid arthritis. Boehringer Ingelheim Inc. launched the drug four years ago for treating osteoarthritis, the most comm…
